source
- Merck grants royalty-free licenses for experimental HIV prevention pill to generic makers in 129 low-income countriesMerck announced voluntary licensing agreements that let generic manufacturers produce its experimental HIV prevention pill, known as alimatravir, in low- and middle-income markets. The deals cover…
- FDA advisory panel votes to expand use of four untested peptides despite safety concernsAn FDA advisory committee narrowly voted to recommend adding four peptides to the agency's 503A Bulks List, a registry that would allow compounding pharmacies to use them in custom medications. The…